Clinical Trial Update: Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Squalamine ophthalmic solution in neovascular age-related macular degeneration. The update does not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Squalamine ophthalmic solution (squalamine)

Snippet

Sponsor: Ohr Pharmaceutical Inc. | Conditions: Age-related Macular Degeneration | Phase 3 | Status: UNKNOWN